Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 14/20 | 0.78 |
| ▸ | MAOB | P27338 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.50 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.50 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.50 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.50 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13410633 | 1.00 | KIF11 (0.78) | KIF11MAOBALDH1A1TSHRCA1 | |
| SCHEMBL29914837 | 1.00 | KIF11 (0.78) | KIF11MAOBALDH1A1TSHRCA1 | |
| SCHEMBL12937177 | 0.91 | KIF11 (0.67) | KIF11MAOBALDH1A1TSHRCA1 | |
| SCHEMBL63468 | 0.89 | ALDH1A1 (0.67) | KIF11ALDH1A1TSHRCES2CES1 | |
| SCHEMBL7940597 | 0.88 | KIF11 (0.64) | KIF11MAOBALDH1A1TSHRCA1 | |
| SCHEMBL163728 | 0.88 | KIF11 (1.00) | KIF11ALDH1A1TSHRTRPV6 | |
| SCHEMBL1044865 | 0.86 | KIF11 (0.61) | KIF11MAOBALDH1A1TSHRCA1 | |
| SCHEMBL13410613 | 0.86 | KIF11 (1.00) | KIF11MAOB | |
| Ammonia Solution, Strong SCHEMBL21809401 | 0.86 | KIF11 (0.95) | KIF11ALDH1A1TSHRTRPV6 | |
| SCHEMBL12675678 | 0.86 | KIF11 (1.00) | KIF11ALDH1A1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108822317-B | Preparation method of graphene polyimide heating film | 杭州牛墨科技有限公司 | 2021-04-06 | — | — | CN | claimed |
| US-12392042-B2 | Alternating current (AC) transition-metal catalysis | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2025-08-19 | — | — | US | disclosed |
| US-20250033002-A1 | Porous Polybenzimidazole Membrane Supports for Composite Membranes | U.S. DEPARTMENT OF ENERGY | 2025-01-30 | — | — | US | disclosed |
| US-12138599-B2 | Porous polybenzimidazole membrane supports for composite membranes | BATTELLE MEMORIAL INSTITUTE (US) | 2024-11-12 | — | — | US | disclosed |
| CN-114605300-B | Synthesis method of aryl selenocyanate compound | 浙江工业大学 | 2024-03-26 | — | — | CN | disclosed |
| US-20230407492-A1 | ALTERNATING CURRENT (AC) TRANSITION-METAL CATALYSIS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2023-12-21 | — | — | US | disclosed |
| CN-114149298-B | Method for preparing biaryl compound from arylboronic acid by hydrazone catalyst | 江西麦豪化工科技有限公司 | 2023-11-24 | — | — | CN | disclosed |
| CN-117075426-A | Curable resin composition, dry film, cured product, and electronic component | 太阳控股株式会社 | 2023-11-17 | — | — | CN | disclosed |
| US-11767473-B2 | Active nematic colloids in microrobotics | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2023-09-26 | — | — | US | disclosed |
| CN-111886293-B | Curable resin composition, dry film, cured product, and electronic component | 太阳控股株式会社 | 2023-08-01 | — | — | CN | disclosed |
| US-7193100-B2 | Haloaluminoxane compositions, their preparation, and their use in catalysis | ALBEMARLE CORPORATION (US) | 2007-03-20 | — | — | US | disclosed |
| WO-2007005364-A2 | HALOALUMINOXANE COMPOSITIONS | ALBEMARLE CORPORATION (US) | 2007-01-11 | — | — | WO | disclosed |
| US-20060287448-A1 | Haloaluminoxane compositions, their preparation, and their use in catalysis | W. R. GRACE & CO-CONN. | 2006-12-21 | — | — | US | disclosed |
| EP-1701963-A1 | HALOALUMINOXANE COMPOSITIONS, THEIR PREPARATION, AND THEIR USE IN CATALYSIS | ALBEMARLE CORPORATION (US) | 2006-09-20 | — | — | EP | disclosed |
| WO-2005066191-A1 | HALOALUMINOXANE COMPOSITIONS, THEIR PREPARATION, AND THEIR USE IN CATALYSIS | ALBEMARLE CORPORATION (US) | 2005-07-21 | — | — | WO | disclosed |
| US-20050143254-A1 | Haloaluminoxane compositions, their preparation, and their use in catalysis | W. R. GRACE & CO.-CONN. | 2005-06-30 | — | — | US | disclosed |
| US-20010034459-A1 | Process for preparing 4'-trifluoromethyl-2-methylbiphenyl and 4'-trifluoromethyl-biphenyl-2-carboxylic acid from o-tolylmetallates | MEUDT ANDREAS (DE) | 2001-10-25 | — | — | US | disclosed |
| EP-1112991-A2 | Process for the preparation of 4'-trifluoromethyl-2-methylbiphenyl and 4'-trifluoromethylbiphenyl-2-carboxylic acid from o-tolylmetallates | Clariant GmbH (DE) | 2001-07-04 | — | — | EP | disclosed |
| EP-0446301-A1 | PREPARATION OF BIARYL COMPOUNDS. | EASTMAN KODAK CO (US) | 1991-09-18 | — | — | EP | disclosed |
| WO-1990006295-A1 | PREPARATION OF BIARYL COMPOUNDS | EASTMAN KODAK COMPANY (US) | 1990-06-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010034459-A1 | Process for preparing 4'-trifluoromethyl-2-methylbiphenyl and 4'-trifluoromethyl-biphenyl-2-carboxylic acid from o-tolylmetallates | ZC3HAV1L, ZRANB2, ZFP3 | KIF11 707/4885MAOB 171/4885ALDH1A1 1678/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.